
Emily Lucy Germain-Lee MD
Pediatric Bone Metabolism Disorders, Pediatric Growth Disorder Endocrinology
Professor, Dept of Pediatrics, Univ of Connecticut School of Medicine; Professor, Dept of Reconstructive Sciences, Univ of Connecticut School of Dental Medicine; Head of Academic Affairs and Research, Pediatric Endocrinology and Diabetes, Connecticut Children's Additional: Director, Center for Rare Bone Disorders; Director, Albright Center; Director, Osteogenesis Imperfecta Center
Join to View Full Profile
505 Farmington AveFarmington, CT 06032
Phone+1 860-837-6700
Fax+1 860-837-6765
Dr. Germain-Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Emily Germain-Lee is a Professor of Pediatrics at the University of Connecticut School of Medicine and Professor of Reconstructive Sciences at the Univ of Connecticut School of Dental Medicine. She is also the Head of Academic Affairs and Research for Pediatric Endocrinology at Connecticut Children's as well as the Director for the Scientific Center for Rare Disease for Connecticut Children's Research Institute. Her research focus is on rare bone disorders, and she established and directs the Center for Rare Bone Disorders, Albright Center, and Osteogenesis Imperfecta Center. She is an NIH-funded laboratory investigator. She received her Bachelor's degree from Harvard University and her M.D. from Johns Hopkins University School of Medicine, where she also completed her residency and pediatric endocrinology fellowship. She then went on to be faculty at Johns Hopkins from 1992 -2016, achieving the rank of Professor. She moved to Connecticut at the end of 2016, and she remains a Professor (Adjunct) at Johns Hopkins. She has been in practice 32 years. She specializes in pediatric bone disorders, especially rare bone disorders, and pediatric growth disorders. Her laboratory focus is on Albright hereditary osteodystrophy, osteogenesis imperfecta, rare bone disorders, and general bone biology. She is experienced in rare bone disorders including pseudohypoparathyroidism (Albright hereditary osteodystrophy) and osteogenesis imperfecta, pediatric endocrinology, pediatric disorders of bone metabolism and genetic bone disorders
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1989 - 1992
Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
Johns Hopkins University School of MedicineInternship, Transitional Year, 1986 - 1987
Johns Hopkins University School of MedicineClass of 1986
Harvard UniversityA.B., Biochemical Studies, magna cum laude, 1977 - 1981
Certifications & Licensure
CT State Medical License 2016 - 2027
MD State Medical License 1988 - 2026
NM State Medical License 2017 - 2018
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Connecticut Academy of Science & Engineering 2019
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015
Clinical Trials
Publications & Presentations
PubMed
- Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright heredi...Patrick McMullan, Peter Maye, Sierra H Root, Qingfen Yang, Sarah Edie
JBMR Plus. 2025-05-01 - Hair follicle-resident progenitor cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy.Patrick McMullan, Peter Maye, Sierra H Root, Qingfen Yang, Sarah Edie
Biorxiv. 2024-06-21 - 4 citationsPrevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.Neetu Krishnan, Patrick McMullan, Qingfen Yang, Alexzandrea N Buscarello, Emily L Germain-Lee
Plos One. 2023-01-01
Press Mentions
Next Generation of Weight Loss Drugs Being Researched at UConnFebruary 25th, 2025- Advocates Fighting for Rare Disease CouncilApril 8th, 2022
- 2021 Research Innovators Named by UConn School of MedicineDecember 21st, 2021
Grant Support
- Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteinsUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2022–2027
- Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteinsUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2022–2027
- Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in miceUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2022–2025
- Role of G protein-coupled signaling in neurocognitive and psychosocial abnormalitiesNIH2016–2019
- Phase 2 Of Growth Hormone For Treatment Of Albright Hereditary OsteodystrophyFood And Drug Administration2010–2011
External Links
- Connecticut Children'shttps://www.connecticutchildrens.org/about-us/find-a-doctor/emily-l-germain-lee-md/
- University of Connecticut School of Medicinehttp://facultydirectory.uchc.edu/profile?profileId=Germain-Lee-Emily
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









